This company has been marked as potentially delisted and may not be actively trading. Tenzing Acquisition (TZAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock TZAC vs. AEON, NRBO, OBSV, CPHI, GRAY, ORGS, ATXI, CANF, EVFM, and ADXSShould you be buying Tenzing Acquisition stock or one of its competitors? The main competitors of Tenzing Acquisition include AEON Biopharma (AEON), NeuroBo Pharmaceuticals (NRBO), ObsEva (OBSV), China Pharma (CPHI), Graybug Vision (GRAY), Orgenesis (ORGS), Avenue Therapeutics (ATXI), Can-Fite BioPharma (CANF), Evofem Biosciences (EVFM), and Ayala Pharmaceuticals (ADXS). Tenzing Acquisition vs. Its Competitors AEON Biopharma NeuroBo Pharmaceuticals ObsEva China Pharma Graybug Vision Orgenesis Avenue Therapeutics Can-Fite BioPharma Evofem Biosciences Ayala Pharmaceuticals AEON Biopharma (NASDAQ:AEON) and Tenzing Acquisition (NASDAQ:TZAC) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability. Is AEON or TZAC more profitable? AEON Biopharma's return on equity of 0.00% beat Tenzing Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets AEON BiopharmaN/A N/A -994.63% Tenzing Acquisition N/A -13.32%-1.36% Do institutionals & insiders hold more shares of AEON or TZAC? 22.8% of AEON Biopharma shares are held by institutional investors. Comparatively, 60.9% of Tenzing Acquisition shares are held by institutional investors. 0.9% of AEON Biopharma shares are held by insiders. Comparatively, 37.5% of Tenzing Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend AEON or TZAC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AEON Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tenzing Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer AEON or TZAC? In the previous week, AEON Biopharma's average media sentiment score of 0.00 equaled Tenzing Acquisition'saverage media sentiment score. Company Overall Sentiment AEON Biopharma Neutral Tenzing Acquisition Neutral Which has better valuation & earnings, AEON or TZAC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAEON BiopharmaN/AN/A-$36.63M-$6.08-0.18Tenzing AcquisitionN/AN/A$620KN/AN/A Which has more volatility & risk, AEON or TZAC? AEON Biopharma has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500. Comparatively, Tenzing Acquisition has a beta of 0.01, meaning that its stock price is 99% less volatile than the S&P 500. SummaryAEON Biopharma and Tenzing Acquisition tied by winning 4 of the 8 factors compared between the two stocks. Get Tenzing Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TZAC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TZAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TZAC vs. The Competition Export to ExcelMetricTenzing AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$2.94M$1.08B$2.48B$10.53BDividend YieldN/A4.84%13.85%4.83%P/E RatioN/A1.3225.8327.13Price / SalesN/A31.087,054.09179.61Price / Cash143.1017.6359.9960.81Price / Book0.598.073.336.52Net Income$620K-$7.36M-$445.27M$276.93M Tenzing Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TZACTenzing AcquisitionN/A$0.57-2.2%N/A-55.1%$2.94MN/A0.00N/AGap DownHigh Trading VolumeAEONAEON Biopharma0.5401 of 5 stars$1.03+12.0%N/A-98.6%$11.99MN/A5.725Gap DownNRBONeuroBo PharmaceuticalsN/A$1.08+1.9%N/A-67.9%$9.31MN/A0.0010Gap UpHigh Trading VolumeOBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050CPHIChina Pharma0.1494 of 5 stars$1.93-2.7%N/A-92.4%$6.31M$4.40M0.00250Negative NewsShort Interest ↑GRAYGraybug VisionN/A$3.19-6.0%N/A-18.9%$5.01MN/A-1.8427Gap DownHigh Trading VolumeORGSOrgenesis1.4774 of 5 stars$0.89+89.4%N/A-92.9%$4.27M$662K0.00150Gap DownATXIAvenue Therapeutics1.9555 of 5 stars$0.71-5.1%N/A-65.4%$2.26MN/A0.044News CoverageCANFCan-Fite BioPharma2.362 of 5 stars$0.57-3.8%$14.50+2,449.7%-82.5%$2.01M$560K-0.328Negative NewsShort Interest ↑High Trading VolumeEVFMEvofem Biosciences1.7046 of 5 stars$0.01+6.3%N/A+0.0%$1.51M$11.39M-0.02120Short Interest ↓Gap DownADXSAyala PharmaceuticalsN/A$0.03flatN/A+23.3%$1.42M$3.24M0.0020 Related Companies and Tools Related Companies AEON Biopharma Competitors NeuroBo Pharmaceuticals Competitors ObsEva Competitors China Pharma Competitors Graybug Vision Competitors Orgenesis Competitors Avenue Therapeutics Competitors Can-Fite BioPharma Competitors Evofem Biosciences Competitors Ayala Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TZAC) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenzing Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenzing Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TZAC Stock Alerts